

Caladrius Biosciences, Inc., through its subsidiary, PCT, is a leading development and manufacturing partner to the cell therapy industry. Among its major competitors, Caladrius Biosciences is ranked in 11th place for NPS while Genentech is 1st, and Bristol Myers Squibb is 2nd.